Rockefeller Capital Management L.P. Anavex Life Sciences Corp. Transaction History

Rockefeller Capital Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$9.74 - $17.69 $14,610 - $26,535	1,500 Added 125.0%	2,700 $33,000
Q3 2021 Nov 12, 2021	BUY	$16.82 - $25.75 $6,728 - $10,300	400 Added 50.0%	1,200 $21,000
Q2 2021 Aug 10, 2021	BUY	$10.16 - $28.86 $3,048 - $8,658	300 Added 60.0%	800 $18,000
Q1 2021 May 11, 2021	BUY	$5.17 - $16.13 $2,585 - $8,064	500 New	500 $7,000

159

31.6M

910K

1.35M

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $352M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.